Search results
Results from the WOW.Com Content Network
Xenotransfusion (from Greek xenos-'strange, foreign'), a form of xenotransplantation, was initially defined as the transfer of blood from one species into the veins of another. [1] In most cases, it is a transfer of blood between a non-human animal and a human. However, further experimentation has been done between various non-human animal species.
A study performed by Giarratana et al. [35] describes a large-scale ex-vivo production of mature human blood cells using hematopoietic stem cells. The cultured cells possessed the same haemoglobin content and morphology as native red blood cells. The authors contend that the cells had a near-normal lifespan, when compared to natural red blood ...
It deals with the concepts and clinical 2 techniques related to modern transfusion therapy. Efforts to save human lives by transfusing blood have been recorded for several centuries. The era of blood transfusion, however, really began when William Harvey described the circulation of blood in 1616.
The ARC provides about 35% of transfused blood in the US. [1] America's Blood Centers (ABC), North America's largest network of non-profit community blood centers. [2] Most of the independent blood centers on this list are ABC members, and these account for approximately 60 percent of the U.S. blood supply. [3]
Thus far, there are no FDA-approved oxygen-carrying blood substitutes, which is the typical objective of a blood (RBC) transfusion. Non-blood volume expanders are available for cases where only volume restoration is required, but a substance with oxygen-carrying capacity would help doctors and surgeons avoid the risks of disease transmission ...
Stem-cell therapy uses stem cells to treat or prevent a disease or condition. [1] As of 2024, the only FDA-approved therapy using stem cells is hematopoietic stem cell transplantation. [2] [3] This usually takes the form of a bone marrow or peripheral blood stem cell transplantation, but the cells can also be derived from umbilical cord blood.
For those with severe forms of thalassemia (thalassemia major, or transfusion-dependent thalassemia), the three principal treatments are red blood cell transfusions to relieve anemia, iron chelation to mitigate the side effects of transfusion, and folic acid supplementation to encourage the growth of new blood cells. [73]
TEM-guided transfusion of blood products or factor concentrates in cardiac, hepatic and major orthopedic surgery is the main application of the method. Moreover, it is successfully used in the complex situation of (poly) trauma , or in decision making for of alternative therapy such as antifibrinolytic drug administration .